EPHEDRINE

The project report includes Present Market Position and Expected Future Demand, Market Size, Statistics, Trends, SWOT Analysis and Forecasts. Report provides a comprehensive analysis from industry covering detailed reporting and evaluates the position of the industry by providing insights to the SWOT analysis of the industry.

We can prepare PROJECT REPORT as per your INVESTMENT PLAN for BANK LOAN REQUIREMENT and INDUSTRY ANALYSIS. All reports are prepared by highly qualified consultants and verified by a panel of experts.

Have Query? Click Here to Chat
Industry Expert is Online, Chat with him for more detail.

Ephedrine is a medication and stimulant. It is often used to prevent low blood pressure during spinal anesthesia. It has also been used for asthma, narcolepsy, and obesity but is not the preferred treatment. It is of unclear benefit in nasal congestion. It can be taken by mouth or by injection into a muscle, vein, or just under the skin. Onset with intravenous use is fast, while injection into a muscle can take 20 minutes, and by mouth can take an hour for effect. When given by injection it lasts about an hour and when taken by mouth it can last up to four hours.

Common side effects include trouble sleeping, anxiety, headache, hallucinations, high blood pressure, fast heart rate, loss of appetite, and inability to urinate. Serious side effects include stroke, heart attack, and abuse. While likely safe in pregnancy, its use in this population is poorly studied. Use during breastfeeding is not recommended. Ephedrine works by increasing the activity of the α and β adrenergic receptors.

Ephedrine was first isolated in 1885 and came into commercial use in 1926. It is on the World Health Organization’s List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication. The wholesale cost in the developing world is about US$0.69–1.35 per dose. In the United States it is not very expensive. It can normally be found in plants of the Ephedra type. Dietary supplements containing ephedrine are illegal in the United States, with the exception of those used in traditional Chinese medicine, where its presence is noted by má huáng.

Ephedrine promotes modest short-term weight loss, specifically fat loss, but its long-term effects are unknown. In mice, ephedrine is known to stimulate thermogenesis in the brown adipose tissue, but because adult humans have only small amounts of brown fat, thermogenesis is assumed to take place mostly in the skeletal muscle. Ephedrine also decreases gastric emptying. Methylxanthines such as caffeine and theophylline have a synergistic effect with ephedrine with respect to weight loss. This led to creation and marketing of compound products. One of them, known as the ECA stack, contains ephedrine with caffeine and aspirin. It is a popular supplement taken by bodybuilders seeking to cut body fat before a competition.

Ephedrine is a sympathomimetic amine used for allergic conditions, CNS (Central Nervous System) stimulation, and prophylaxis and treatment of hypotension. It is useful as an adjunct to neostigmine in the treatment of myasthenia gravis. Either the sulphate or hydrochloride is used for the systemic effects of the alkaloid. Sterile solutions can be injected subcutaneously, intramuscularly, or intravenously. Tropical
application to the respiratory or conjuctival mucosa is common.

1. AO.5 – 1.0% solution is used as a nasal decongestant.

2. A 4% solution is used as a mydriatic.

3. The 1-3% solution of the free base in oil is available for tropical use.

The preferred natural source of ephedrine is “Ma Haung” which is a mixture of E. equisetina, E. Sinica, and E. distachya. The yield of crude alkaloid is in the range of 0.5. – 2%, depending on the species, of this, upto 90% may be ephedrine. Ephedrine is soluble in water, alcohol, chloroform, and ether. It melts over a range of 33-42~c, depending on the water content.

Category: Tag:

Description

INTRODUCTION
PROPERTIES OF EPHEDRINE
PROPERTIES OF EPHEDRINE HYDROCHLORIDE
CLASSIFICATION (FORMS)
NOMENCLATURE
GRADES
MECHANISM OF ACTION
COMPOUNDS WITH DECREASING Α-RECEPTOR AFFINITY
MEDICAL USE
OTHER USES
USES AND APPLICATIONS
CHEMISTRY AND NOMENCLATURE OF EPHEDRINE
CONTRAINDICATION AND ADVERSE EFFECTS OF EPHEDRINE
ADVERSE EFFECTS
STRUCTURE OF EPHEDRINES
FIGURE: FREUDENBERG AND LEITHE REPRESENTATION OF EPHEDRINE
1A AND PSEUDOEPHEDRINE 2A.
FIGURE. STABLE CONFORMATIONS OF EPHEDRINE 1B AND PSEUDOEPHEDRINE
FIGURE. EPHEDRINE STEREOISOMERS.
FIGURE: NOREPHEDRINE STEREOISOMERS.
PHYSICAL PROPERTIES OF EPHEDRINES
MARKET SURVEY AND GROWTH ASPIRATION OF INDIAN
PHARMACEUTICAL INDUSTRY
OPPORTUNITIES AND CHALLENGES FOR ACHIEVING VISION 2030
OPPORTUNITIES
EXHIBIT 3
PATENT ANALYSIS
A FOOTPRINT IN UNDERPENETRATED INTERNATIONAL MARKETS
COULD INCREASE EXPORTS
LEVERAGE INDIA’S STRENGTHS IN IT AND ITES – OPTIMIZE NEW
AVENUES SUCH AS OTC
CHALLENGES
INDIA IS YET TO ACHIEVE UNIVERSAL HEALTHCARE ACCESS
LACK OF A STABLE PRICING AND POLICY ENVIRONMENT FAVOURABLE
FOR LONG-TERM INVESTMENT DECISIONS
LACK OF CAPABILITIES IN THE INNOVATION SPACE
DEPENDENCE ON EXTERNAL MARKETS FOR INTERMEDIATES AND APIS
INDIAN PHARMA’S ERODING COMPETITIVE ADVANTAGE IN THE US
GENERICS MARKET & LIMITED PRESENCE IN OTHER MARKETS
AND PRODUCTS
INCREASED SCRUTINY IN QUALITY COMPLIANCE WHEN SUPPLYING
TO INTERNATIONAL MARKETS
OVERVIEW OF INDIAN PHARMACEUTICAL INDUSTRY
IMPORT DATA OF EPHEDRINE
EXPORT DATA OF EPHEDRINE
MARKET POSITION OF API (ACTIVE PHARMA INGREDIENT)
INDIA API MARKET TRADE (%), FY 2016
SHARE OF INDIA IN GLOBAL API MARKET (%), FY 2016
SHARE OF INDIA IN GLOBAL API MARKET
INDIAN API DOMESTIC CONSUMPTION MARKET FUTURE OUTLOOK
INDIAN API DOMESTIC CONSUMPTION MARKET (BILLION US$),
FY 2015-FY 2022
MAJOR APIS IN THE INDIAN API MARKET
MAJOR APIS IN THE INDIAN API MARKET
DRIVERS
RISING HEALTHCARE EXPENDITURE
HEALTHCARE EXPENDITURE (US$ PER HEAD), 2012-2016
INCREASING DISPOSABLE INCOMES
PERSONAL DISPOSABLE INCOME (TRILLION US$), 2012-2016
GROWING GERIATRIC POPULATION
INDIAN POPULATION – 60 YEARS OR ABOVE (MILLION), 2015 & 2030
INCREASING INCIDENCES OF CHRONIC DISEASES
CARDIOVASCULAR DISEASES
DIABETES
INDIA – NUMBER OF PEOPLE WITH DIABETES (MILLION), 2015 & 2040
PATENT EXPIRY OF BLOCKBUSTER DRUGS
LIST OF BLOCKBUSTER DRUGS LOSING PATENT (2016-2022)
INCREASED CONSUMPTION OF GENERIC DRUGS
INVENTION OF NEW GENERATION OF APIS
CHALLENGES
OVER DEPENDENCE ON CHINA FOR IMPORTS
API IMPORT FROM CHINA (BILLION US$), FY 2012 TO FY 2015
THE REASONS FOR LOW MANUFACTURING COST OF API IN CHINA ARE:
GLOBAL MARKET POSITION OF EPHEDRINE
PRODUCTION SCHEMES OF EPHEDRINE
PRODUCTION SCHEMES OF EPHEDRINE
(1) EXTRACTION FROM EPHEDRA PLANTS
(2) FERMENTATION OF SUGAR FOLLOWED BY AMINATION
(3) CHEMICAL SYNTHESIS: BROMINATION OF PROPIOPHENONE
FOLLOWED BY AMINATION
PROCESS OF MANUFACTURE
MANUFACTURING PROCESS:-
REACTION WITH ACTIVELY FERMENTING GLUCOSE SOLUTION:-
CONDENSATION WITH METHYLAMINE:-
REDUCTION TO PRODUCE 1-EPHEDRINE:-
CONVERSION TO EPHEDRINE HYDROCHLORIDE:-
PACKING AND FORWARDING:-
PROCESS FLOW SHEET FOR THE MANUFACTURE OF
EPHEDRINE HYDROCHLORIDE (KETOL)
BIOSYNTHETICS OF EPHEDRINE (ORGANIC)
OTHER METHODS:
PREPARATION OF PROPIONYL CHLORIDE AND PROPIOPHENONE
EPHEDRONE [Α-METHYLAMINOETHYL PHENYL KETONE]
DL -EPHEDRINE HYDROCHLORIDE
SYNTHESIS
ANOTHER METHOD:
DL -EPHEDRINE HYDROCHLORIDE
METHOD FOR MANUFACTURING EPHEDRINE OR PSEUDOEPHEDRINE
METHYLAMINE SOLUTION PREPARING THESE SOLVENTS, THERE
ARE TWO WAYS:
MANUFACTURING PROCESS OF PSEUDO EPHEDRINE HCL
THE PROCESSING STAGES ARE AS FOLLOWS:-
STAGE-1
STAGE-2
STAGE-3
STAGE-4
PROCESS FLOW DIAGRAM
INNOVATION TWO STAGE PROCESS FOR THE MANUFACTURE
OF EPHEDRINE
STAGE 1
STAGE 2
EPHEDRINE AND ITS SALTS ISOLATION AND PROPERTIES
EXPERIMENTAL
EXTRACTION
PREPARATION OF EPHEDRINE HCL BY FRACTIONAL CRYSTALLIZATION
SEPARATION OF THE OXALATES BY DIFFERENCE OF SOLUBILITY
PREPARATION OF PURE EPHEDRINE BASE
PROPERTIES OF PURE EPHEDRINE
PSEUDOEPHEDRINE
ACTION OF HCL UPON EPHEDRINE. PREPARATION OF PSEUDOEPHEDRINE.
THE MODELING AND 3D STRUCTURES OF EPHEDRINE HYDROCHLORIDE
RAMAN SPECTRUM OF EPHEDRINE HYDROCHLORIDE
PLANT LAYOUT
SUPPLIERS OF RAW MATERIALS
SUPPLIERS OF PLANT & MACHINERY

APPENDIX – A:

01. PLANT ECONOMICS
02. LAND & BUILDING
03. PLANT AND MACHINERY
04. OTHER FIXED ASSESTS
05. FIXED CAPITAL
06. RAW MATERIAL
07. SALARY AND WAGES
08. UTILITIES AND OVERHEADS
09. TOTAL WORKING CAPITAL
10. TOTAL CAPITAL INVESTMENT
11. COST OF PRODUCTION
12. TURN OVER/ANNUM
13. BREAK EVEN POINT
14. RESOURCES FOR FINANCE
15. INSTALMENT PAYABLE IN 5 YEARS
16. DEPRECIATION CHART FOR 5 YEARS
17. PROFIT ANALYSIS FOR 5 YEARS
18. PROJECTED BALANCE SHEET FOR (5 YEARS)

Additional information

Plant Capacity

5.00 TON/day
Land & Building

(3000 sq.mt.)
Plant & Machinery

US$ 441428
Rate of Return

42%
Break Even Point

34%

Related products